The US FDA is seeking paediatric formulations of oral anticancer drugs

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1413, 2003-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Initiative to tackle counterfeit drugs announced by US FDA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

By Peters Eric J   Motsinger-Reif Alison   Havener Tammy M   Everitt Lorraine   Hardison Nicholas E   Watson Venita G   Wagner Michael   Richards Kristy L   Province Mike A   McLeod Howard L  

Pharmacogenomics, Vol. 12, Iss. 10, 2011-10 ,pp. : 1407-1415

Future Medicine

Access to resources Recommend Favorite

DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA

By Lesko Lawrence J   Zineh Issam  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 507-512

Future Medicine

Access to resources Recommend Favorite

Oral Anticancer Drugs in the Elderly: An Overview

By Lonardi Sara   Bortolami Alberto   Stefani Micaela   Monfardini Silvio  

Drugs & Aging, Vol. 24, Iss. 5, 2007-01 ,pp. : 395-410

Adis International

Access to resources Recommend Favorite

US FDA panel advises banning of two asthma drugs

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite